EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review

Carmen Kut, Lawrence Kleinberg

Chinese Clinical Oncology · 2023-02 · 12 (1) · 4-4

DOI: 10.21037/cco-22-94 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chinese Clinical Oncology, 2023-02. Verfasst von Carmen Kut und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Lymphopenia. Die Arbeit wurde bisher 16-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaLymphopeniaHumansTemozolomideTreatment OutcomeRadiotherapy

Stichwörter der Autor:innen

Glioblastomaimmunomodulationradiotherapytreatment-related lymphopeniatumor microenvironment

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Zitieren

APA

Kut, C., & Kleinberg, L. (2023). Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review. Chinese Clinical Oncology, 12(1), 4-4. https://doi.org/10.21037/cco-22-94

Vancouver

Kut C, Kleinberg L. Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review. Chinese Clinical Oncology. 2023;12(1):4-4. doi:10.21037/cco-22-94

BibTeX
@article{Kut2023,
  author = {Kut, Carmen and Kleinberg, Lawrence},
  title = {Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review},
  journal = {Chinese Clinical Oncology},
  year = {2023},
  volume = {12},
  number = {1},
  pages = {4--4},
  doi = {10.21037/cco-22-94}
}
Kostenlos starten →